{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:23:17Z","timestamp":1782948197943,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004504","name":"Research Council of Lithuania","doi-asserted-by":"publisher","award":["S-MIP-17-87"],"award-info":[{"award-number":["S-MIP-17-87"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bmc.2017.12.035","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T20:35:32Z","timestamp":1514061332000},"page":"675-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors"],"prefix":"10.1016","volume":"26","author":[{"given":"Edita","family":"\u010capkauskait\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrius","family":"Zak\u0161auskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginijus","family":"Ruibys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaida","family":"Linkuvien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaida","family":"Paketuryt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Gedgaudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visvaldas","family":"Kairys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daumantas","family":"Matulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.12.035_b0005","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2017.12.035_b0010","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2017.12.035_b0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2017.12.035_b0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756366.2012.737323","article-title":"Structural annotation of human carbonic anhydrases","volume":"28","author":"Aggarwal","year":"2013","journal-title":"J Enz Inh Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/156802607780636690","article-title":"Carbonic anhydrases as drug targets - an overview","volume":"7","author":"Supuran","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-94-007-7359-2_2","article-title":"Physiological functions of the alpha class of carbonic anhydrases","volume":"75","author":"Frost","year":"2014","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bmc.2017.12.035_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/453543","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","volume":"2015","author":"Pinard","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmc.2017.12.035_b0040","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1073\/pnas.97.4.1677","article-title":"Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles","volume":"97","author":"Shah","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2017.12.035_b0045","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1152\/jappl.1987.63.5.2134","article-title":"Inhibition of mitochondrial carbonic anhydrase and ureagenesis: a discrepancy examined","volume":"63","author":"Dodgson","year":"1987","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.bmc.2017.12.035_b0050","first-page":"E791","article-title":"Mitochondrial carbonic anhydrase is involved in rat renal glucose synthesis","volume":"257","author":"Dodgson","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bmc.2017.12.035_b0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0305-0491(96)00116-2","article-title":"Carbonic anhydrase provides bicarbonate for de novo lipogenesis in the locust","volume":"115","author":"Chegwidden","year":"1996","journal-title":"Comp Biochem Physiol B: Biochem Mol Biol"},{"key":"10.1016\/j.bmc.2017.12.035_b0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1096\/fasebj.10.4.8647347","article-title":"Differentiation-dependent expression of CA V and the role of carbonic anhydrase isozymes in pyruvate carboxylation in adipocytes","volume":"10","author":"Hazen","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2017.12.035_b0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj3100197","article-title":"Role of hepatic carbonic anhydrase in de novo lipogenesis","volume":"310","author":"Lynch","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2017.12.035_b0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/bst0160973","article-title":"Effect of the carbonic anhydrase inhibitor acetazolamide on lipid synthesis in the locust","volume":"1988","author":"Spencer","year":"1988","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bmc.2017.12.035_b0075","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bmc.2012.06.053","article-title":"Effect of sulfonamides as carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion","volume":"21","author":"Arechederra","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/ajp.156.6.968a","article-title":"Mood stabilization and weight loss with topiramate","volume":"156","author":"Gordon","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bmc.2017.12.035_b0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/oby.2000.84","article-title":"Topiramate reduces energy and fat gains in lean (Fa\/?) and obese (fa\/fa) Zucker rats","volume":"8","author":"Picard","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.bmc.2017.12.035_b0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1358\/dot.2005.41.9.921095","article-title":"Zonisamide review of its use in epilepsy therapy","volume":"41","author":"Zareba","year":"2005","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.bmc.2017.12.035_b0095","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0960-894X(03)00029-5","article-title":"Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates\/sulfamides with isozymes I, II and IV","volume":"13","author":"Casini","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0100","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1528-1157.2000.tb06047.x","article-title":"Topiramate as an inhibitor of carbonic anhydrase isoenzymes","volume":"41","author":"Dodgson","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.bmc.2017.12.035_b0105","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0110","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/jm031057+","article-title":"Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides","volume":"47","author":"Vullo","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0115","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.bmcl.2005.03.032","article-title":"Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies","volume":"15","author":"Simone","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0120","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.bmc.2007.03.070","article-title":"Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA","volume":"15","author":"Vitale","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0125","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1016\/j.bmc.2009.06.006","article-title":"Carbonic anhydrase inhibitors. Aromatic\/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB","volume":"17","author":"G\u00fczel","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0130","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1016\/j.bmcl.2013.08.019","article-title":"Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII","volume":"2013","author":"Biswas","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0135","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.bmcl.2009.04.123","article-title":"Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors","volume":"19","author":"G\u00fczel","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0140","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1016\/j.bmc.2013.08.011","article-title":"Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition","volume":"21","author":"G\u00fczel-Akdemir","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0145","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1021\/jm200209n","article-title":"Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV","volume":"54","author":"Hen","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0150","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1016\/j.bmcl.2008.07.010","article-title":"Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives","volume":"18","author":"Poulsen","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0155","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.bmcl.2007.03.008","article-title":"Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails","volume":"17","author":"Winum","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0160","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1016\/j.bmcl.2008.10.093","article-title":"Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV","volume":"18","author":"Smaine","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0165","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.bmcl.2011.01.050","article-title":"(R)-\/(S)-10-camphorsulfonyl-substituted aromatic\/heterocyclic sulfonamides selectively inhibit mitochondrial over cytosolic carbonic anhydrases","volume":"21","author":"Maresca","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0170","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1016\/j.bmcl.2005.08.102","article-title":"Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides","volume":"15","author":"Cecchi","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bmc.2009.11.021","article-title":"Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library","volume":"18","author":"Davis","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/14756366.2011.650692","article-title":"Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors","volume":"28","author":"Bonneau","year":"2013","journal-title":"J Enz Inhib Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0185","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.bmcl.2012.01.129","article-title":"New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II","volume":"22","author":"Carta","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.035_b0190","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.bmc.2010.09.016","article-title":"Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII","volume":"18","author":"\u010capkauskait\u0117","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/14756366.2012.757223","article-title":"Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII","volume":"29","author":"Zubrien\u0117","year":"2014","journal-title":"J Enz Inhib Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0200","first-page":"5360","article-title":"Combinatorial approach to build selective inhibitors of carbonic anhydrases: N-alkylated benzimidazoles, their affinities to all 12 human CA isoforms","volume":"2","author":"\u010capkauskait\u0117","year":"2017","journal-title":"Chem Select"},{"key":"10.1016\/j.bmc.2017.12.035_b0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0022-2860(84)87226-9","article-title":"Solution-state conformations of 2-fluoro-, 2-chloro- and 2-bromo-acetophenone: a dipole moment and kerr effect study","volume":"118","author":"Mirarchi","year":"1984","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2017.12.035_b0210","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1021\/jo0162179","article-title":"Characterization of rotameric mixtures in o- and m-substituted benzaldehydes by matrix isolation IR spectroscopy","volume":"67","author":"Bednarek","year":"2002","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jlac.19616410109","article-title":"3-Alkyl-6-Halogen-Aniline Aus p-Halogenierten Fettaromatischen Ketonen","volume":"641","author":"Oelschlager","year":"1961","journal-title":"Justus Liebigs Ann Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0220","unstructured":"Lang HJDCD., Muschaweck RD. Thiazolidinderivate und verfahren zu ihrer herstellung. Patent DE 2533821 A1; 1977."},{"key":"10.1016\/j.bmc.2017.12.035_b0225","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1248\/cpb.30.4092","article-title":"Studies on benzenesulfonamide derivatives with alpha- and beta-adrenergic antagonistic and antihypertensive activities","volume":"30","author":"Fujikura","year":"1982","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmc.2017.12.035_b0230","unstructured":"Habicht, E.D., Ferrini, P.G.D. and Sallmann, A.D. Verfahren zur herstellung von acylierten heterocyclylcarbonsaeuren A process for preparing acylated heterocyclylcarbonsaeuren. Patent DE 2737462 A1, 1978."},{"key":"10.1016\/j.bmc.2017.12.035_b0235","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1021\/jm501003k","article-title":"Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX","volume":"57","author":"Dudutien\u0117","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0240","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1016\/j.bmc.2013.09.029","article-title":"Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII","volume":"21","author":"\u010capkauskait\u0117","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0245","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1529\/biophysj.108.134973","article-title":"A quantitative model of thermal stabilization and destabilization of proteins by ligands","volume":"95","author":"Cimmperman","year":"2008","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2017.12.035_b0250","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1016\/j.bmc.2010.09.011","article-title":"4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII","volume":"18","author":"S\u016bd\u017eius","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0255","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.bmc.2012.10.016","article-title":"Characterization of human carbonic anhydrase XII stability and inhibitor binding","volume":"21","author":"Jogait\u0117","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0260","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/14756360903571685","article-title":"Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides","volume":"25","author":"Baranauskien\u0117","year":"2010","journal-title":"J Enz Inhib Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bpc.2015.05.009","article-title":"Intrinsic thermodynamics of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry","volume":"205","author":"Zubrien\u0117","year":"2015","journal-title":"Biophys Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0270","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1021\/bi00063a017","article-title":"Thermodynamics of binding of the carbon dioxide-competitive inhibitor imidazole and related compounds to human carbonic anhydrase I: an isothermal titration calorimetry approach to studying weak binding by displacement with strong inhibitors","volume":"32","author":"Khalifah","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2017.12.035_b0275","doi-asserted-by":"crossref","first-page":"D387","DOI":"10.1093\/nar\/gkn750","article-title":"The SWISS-MODEL Repository and associated resources","volume":"37","author":"Kiefer","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2017.12.035_b0280","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera? A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0285","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.bmc.2017.12.035_b0290","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jcc.540130714","article-title":"Validation of the general purpose QUANTA \u00ae3.2\/CHARMm\u00ae force field","volume":"13","author":"Momany","year":"1992","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0295","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jcc.10168","article-title":"Enhanced docking with the mining minima optimizer: acceleration and side-chain flexibility","volume":"23","author":"Kairys","year":"2002","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1008128723048","article-title":"Ligand-receptor docking with the Mining Minima optimizer","volume":"15","author":"David","year":"2001","journal-title":"J Computer-Aided Mol Des"},{"key":"10.1016\/j.bmc.2017.12.035_b0305","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X","article-title":"MMFF VI. MMFF94s option for energy minimization studies","volume":"20","author":"Halgren","year":"1999","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminf"},{"key":"10.1016\/j.bmc.2017.12.035_b0315","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/bi00574a022","article-title":"Side-chain torsional potentials: effect of dipeptide, protein, and solvent environment","volume":"18","author":"Gelin","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2017.12.035_b0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2012.02.050","article-title":"Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases","volume":"51","author":"\u010capkauskait\u0117","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.035_b0325","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/ct049875k","article-title":"Histidine\u2212aromatic interactions in proteins and protein\u2212ligand complexes: quantum chemical study of X-ray and model structures","volume":"2005","author":"Cau\u00ebt","year":"2005","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2017.12.035_b0330","doi-asserted-by":"crossref","first-page":"e36899","DOI":"10.1371\/journal.pone.0036899","article-title":"Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90","volume":"7","author":"Kazlauskas","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617322320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617322320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:52:17Z","timestamp":1760835137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089617322320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0968089617322320"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.12.035","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}